Original Article from The New England Journal of Medicine — Mepolizumab for Eosinophilic…
nejm.org
Fasenra (benralizumab) receives US FDA approval for severe eosinophilic asthma
Fasenra (benralizumab) receives US FDA approval for severe eosinophilic asthma PUBLISHED 14 November 2017 Fasenra distinctively targets and rapidly depletes eosinophils and is the first respiratory biologic with an 8-week maintenance dosing schedule FDA approval based on Phase III programme demonstr…
astrazeneca.com
The definition of eosinophilic pneumonia depends on clinical context. In pathology, eosinophilic…
emedicine.medscape.com